| Serial Number | 99259760 |
| Word Mark | OCULAR THERAPEUTIX |
| Filing Date | Monday, June 30, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, December 29, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 20, 2026 |
| NOT AVAILABLE | OCULAR THERAPEUTICS |
| Goods and Services | Research and development in the field of pharmaceuticals and biopharmaceuticals; Product development in the field of pharmaceutical and biopharmaceutical preparations, inserts being implantable intravitreal drug delivery devices, implants, and medicines; Development of pharmaceutical preparations and medicines; Product development in the field of pharmaceuticals and biopharmaceuticals |
| Goods and Services | Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, macular degeneration, and lowering intraocular pressure, namely, ophthalmic pharmaceutical preparations that are delivered using implantable intravitreal drug delivery devices that are filled and sold with ophthalmic pharmaceutical preparations; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, and macular degeneration; Pharmaceutical preparations for the treatment of lowering intraocular pressure; Pharmaceutical preparations for the treatment of eye diseases and conditions, namely, dexamethasone that is delivered using implantable intravitreal drug delivery devices that are filled and sold with dexamethasone; Pharmaceutical preparations for the treatment of post-op pain and inflammation of the eye, and itching associated with allergic conjunctivitis, namely dexamethasone that is delivered using implantable intravitreal drug delivery devices that are filled and sold with dexamethasone; Ophthalmic preparations |
| Description of Mark | The mark consists of the word OCULAR positioned above the stylized word THERAPEUTIX. Above and below the letter O, there are two curved rows of small circles, forming in combination with the letter "O", a stylized representation of an eye. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 30, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | OCULAR THERAPEUTIX, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Bedford, MA 01730 |
| Event Date | Event Description |
| Monday, June 30, 2025 | NEW APPLICATION ENTERED |
| Monday, June 30, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, November 7, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 7, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, November 18, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, November 18, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 18, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 18, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 17, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 17, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 17, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 18, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |